BioCentury | May 14, 2020
Emerging Company Profile

Kriya emerges with $80.5M A round, three gene therapies for diabetes and obesity

...and obesity. QVT and Dexcel Pharma led the A round, and Foresite Capital, Bluebird Ventures, Narya Capital...
...8 Funds raised: More than $80.5 million Investors: QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures, Narya Capital...
Items per page:
1 - 1 of 1
BioCentury | May 14, 2020
Emerging Company Profile

Kriya emerges with $80.5M A round, three gene therapies for diabetes and obesity

...and obesity. QVT and Dexcel Pharma led the A round, and Foresite Capital, Bluebird Ventures, Narya Capital...
...8 Funds raised: More than $80.5 million Investors: QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures, Narya Capital...
Items per page:
1 - 1 of 1